Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | AMGN | GILD | CELG | BIIB |
| Company | Clovis Oncology Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0808 | 264.63 | 66.25 | 108.01 | 190.72 |
| High | 0.0977 | 268.79 | 66.72 | 108.59 | 193.18 |
| Low | 0.0766 | 260.68 | 66.16 | 107.27 | 189.44 |
| Last | 0.0812 | 269.24 | 66.72 | 108.24 | 193.85 |
| Change | -0.0048 | +6.49 | +0.56 | +0.11 | +3.33 |
| % Change | -5.58% | +2.47% | +0.85% | +0.10% | +1.75% |
| Volume | 24,516,400 | 1,647,748 | 4,593,952 | 191,230,496 | 852,897 |
| 20-Day Average Volume | 9,433,500 | 2,155,164 | 6,144,084 | 16,188,930 | 1,101,735 |
| Previous Close | 0.0860 | 262.75 | 66.16 | 108.13 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 272.51 | 69.89 | 108.17 | 204.95 |
| 20-Day Raw Stochastic | 1.73% | 25.86% | 7.53% | 63.25% | 10.49% |
| 20-Day Relative Strength | 23.83% | 42.84% | 29.87% | 64.69% | 30.24% |
| Weighted Alpha | -91.19 | +7.10 | -24.73 | +46.30 | -37.72 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 100% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 72% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | +0.23% since 04/12/24 | -2.31% since 04/12/24 | -1.97% since 11/13/19 | -2.72% since 04/12/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 189.44 on 04/19/24 |
| High | 0.1439 on 12/14/22 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 110.53 on 11/14/19 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -1.41% since 03/19/24 | -9.41% since 03/19/24 | +5.14% since 10/18/19 | -11.82% since 03/19/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 0.3772 on 12/01/22 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -12.97% since 01/19/24 | -23.82% since 01/19/24 | +13.63% since 08/20/19 | -22.88% since 01/19/24 |
| Low | 0.0760 on 12/16/22 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 1.3100 on 10/04/22 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 110.70 on 11/13/19 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -4.53% since 10/19/23 | -15.22% since 10/19/23 | +14.14% since 05/20/19 | -25.08% since 10/19/23 |
| Low | 0.0760 on 12/16/22 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 3.2500 on 07/08/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 140,812,720 | 82,374,304 | 77,035,920 | 27,694,178 |
| Shares Outstanding, K | 144,955 | 535,919 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 148,760,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -264,520,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 30,660,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -56,010,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 0.24 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 2.95 on 02/13/24 |
| Latest Earnings Date | 11/09/22 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 10.99 | 13.05 |